Steven A. Miles

Oncology

8631 W 3rd St Ste 1017E
Los Angeles, CA 90048

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma.

Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: January 27, 2025

Recent advances in the management of hepatocellular carcinoma.

Recent advances in the management of hepatocellular carcinoma.

Journal: Clinical and molecular hepatology

Published: March 26, 2023

Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Journal: The oncologist

Published: January 15, 2017

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.

Journal: Oncotarget

Published: August 02, 2016

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

Journal: The Lancet. Oncology

Published: November 28, 2012

Showing 1-5 of 5

Last Updated: 09/26/2026